BillionToOne (BLLN) SVP sells 1,417 shares in Rule 10b5-1 planned trade
Rhea-AI Filing Summary
BillionToOne, Inc. senior vice president of laboratory operations John Roderick ten Bosch reported selling 1,417 shares of Class A Common Stock on August 10, 2026 at $92.86 per share. After this sale, he held 27,884 shares directly. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 1,417 shares
Net Sell
1 txn
Insider
ten Bosch John Roderick
Role
SVP of Laboratory Operations
Sold
1,417 shs ($132K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1 | 1,417 | $92.86 | $132K |
Holdings After Transaction:
Class A Common Stock — 27,884 shares (Direct)
Footnotes (1)
- F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
Key Figures
Shares sold: 1,417 shares
Sale price per share: $92.86 per share
Shares held after transaction: 27,884 shares
+1 more
4 metrics
Shares sold
1,417 shares
Class A Common Stock sold on August 10, 2026
Sale price per share
$92.86 per share
Price for the August 10, 2026 sale transaction
Shares held after transaction
27,884 shares
Direct holdings after the reported sale
Rule 10b5-1 plan adoption date
March 6, 2026
Date the trading plan governing this sale was adopted
Key Terms
Rule 10b5-1 trading plan, Class A Common Stock, Form 4
3 terms
Rule 10b5-1 trading plan regulatory
"The transactions were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class A Common Stock financial
"security_title is listed as Class A Common Stock for this sale"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Form 4 regulatory
"The transactions reported on this Form 4 were effected pursuant"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did BillionToOne (BLLN) report in this Form 4?
BillionToOne reported that executive John Roderick ten Bosch sold 1,417 shares of Class A Common Stock on August 10, 2026 at a price of $92.86 per share in a planned transaction.
Was the BillionToOne (BLLN) insider sale under a Rule 10b5-1 plan?
Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by John Roderick ten Bosch on March 6, 2026, indicating the transaction was pre-arranged rather than discretionary.
What role does the reporting person hold at BillionToOne (BLLN)?
The reporting person, John Roderick ten Bosch, serves as SVP of Laboratory Operations at BillionToOne, Inc., according to the Form 4, and is therefore a company officer subject to insider reporting requirements.
Is the BillionToOne (BLLN) insider transaction a purchase or a sale?
The reported transaction is a sale of Class A Common Stock. John Roderick ten Bosch disposed of 1,417 shares at $92.86 per share, and no purchases or option exercises are disclosed in this Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.